$ICUI
ICU Medical Inc

2015 Q4 Form 10-Q Financial Statement

#000088398415000046 Filed on November 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $90.39M $86.02M $77.46M
YoY Change 13.13% 11.05% -6.47%
Cost Of Revenue $42.10M $39.75M $39.31M
YoY Change 4.73% 1.12% -6.09%
Gross Profit $48.26M $46.27M $38.15M
YoY Change 21.6% 21.28% -6.86%
Gross Profit Margin 53.39% 53.79% 49.25%
Selling, General & Admin $22.50M $20.21M $21.84M
YoY Change 10.84% -7.49% -2.48%
% of Gross Profit 46.63% 43.67% 57.26%
Research & Development $4.100M $4.227M $5.055M
YoY Change -19.61% -16.38% 60.99%
% of Gross Profit 8.5% 9.14% 13.25%
Depreciation & Amortization $4.800M $4.300M $4.900M
YoY Change 0.0% -12.24% 0.0%
% of Gross Profit 9.95% 9.29% 12.85%
Operating Expenses $26.60M $21.50M $29.74M
YoY Change 5.14% -27.71% 16.44%
Operating Profit $21.66M $24.77M $8.409M
YoY Change 50.55% 194.54% -45.45%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $100.0K $230.0K $155.0K
YoY Change -50.0% 48.39% -18.42%
Pretax Income $12.60M $25.00M $8.564M
YoY Change 3.28% 191.9% -45.12%
Income Tax $7.200M $8.732M $2.136M
% Of Pretax Income 57.14% 34.93% 24.94%
Net Earnings $5.463M $16.27M $6.428M
YoY Change -25.9% 153.05% -41.74%
Net Earnings / Revenue 6.04% 18.91% 8.3%
Basic Earnings Per Share $0.34 $1.02 $0.42
Diluted Earnings Per Share $0.33 $0.98 $0.42
COMMON SHARES
Basic Shares Outstanding 15.98M shares 15.89M shares 15.32M shares
Diluted Shares Outstanding 16.58M shares 15.49M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $377.4M $394.1M $329.7M
YoY Change 8.82% 19.53% 26.42%
Cash & Equivalents $336.2M $355.4M $252.2M
Short-Term Investments $41.20M $38.70M $77.50M
Other Short-Term Assets $11.70M $20.90M $11.80M
YoY Change 11.43% 77.12% 26.88%
Inventory $43.63M $40.68M $38.25M
Prepaid Expenses
Receivables $57.85M $49.24M $35.35M
Other Receivables $14.40M $8.800M $9.300M
Total Short-Term Assets $505.0M $513.7M $424.5M
YoY Change 16.76% 21.01% 16.68%
LONG-TERM ASSETS
Property, Plant & Equipment $74.32M $78.77M $88.53M
YoY Change -13.67% -11.03% -0.41%
Goodwill $6.463M $1.478M $1.478M
YoY Change 337.28% 0.0% 0.0%
Intangibles $23.94M $6.365M $7.394M
YoY Change 238.89% -13.92% -16.39%
Long-Term Investments
YoY Change
Other Assets $17.10M $9.900M $5.800M
YoY Change 83.87% 70.69% 3.57%
Total Long-Term Assets $121.8M $96.53M $103.2M
YoY Change 12.2% -6.47% -1.57%
TOTAL ASSETS
Total Short-Term Assets $505.0M $513.7M $424.5M
Total Long-Term Assets $121.8M $96.53M $103.2M
Total Assets $626.8M $610.2M $527.7M
YoY Change 15.84% 15.64% 12.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.67M $14.73M $11.93M
YoY Change 20.14% 23.47% 10.21%
Accrued Expenses $28.95M $22.47M $17.32M
YoY Change 66.85% 29.76% 6.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $42.62M $37.20M $29.25M
YoY Change 48.35% 27.19% 8.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.000M $2.800M $2.700M
YoY Change 11.11% 3.7% -18.18%
Total Long-Term Liabilities $3.000M $2.800M $2.700M
YoY Change 11.11% 3.7% -18.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.62M $37.20M $29.25M
Total Long-Term Liabilities $3.000M $2.800M $2.700M
Total Liabilities $47.00M $43.10M $36.30M
YoY Change 42.86% 18.73% 0.55%
SHAREHOLDERS EQUITY
Retained Earnings $453.9M $448.4M $401.5M
YoY Change 11.0% 11.68% 8.75%
Common Stock $146.7M $136.0M $95.44M
YoY Change 34.75% 42.51% 33.12%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $1.000K
YoY Change -99.99%
Treasury Stock Shares 0.000 shares 0.000 shares
Shareholders Equity $579.9M $567.2M $491.4M
YoY Change
Total Liabilities & Shareholders Equity $626.8M $610.2M $527.7M
YoY Change 15.84% 15.64% 12.6%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $5.463M $16.27M $6.428M
YoY Change -25.9% 153.05% -41.74%
Depreciation, Depletion And Amortization $4.800M $4.300M $4.900M
YoY Change 0.0% -12.24% 0.0%
Cash From Operating Activities $6.300M $19.40M $19.00M
YoY Change -48.78% 2.11% 17.28%
INVESTING ACTIVITIES
Capital Expenditures -$5.400M -$3.100M -$2.500M
YoY Change 170.0% 24.0% -32.43%
Acquisitions
YoY Change
Other Investing Activities -$31.00M $1.200M $700.0K
YoY Change -684.91% 71.43% 40.0%
Cash From Investing Activities -$36.40M -$1.900M -$1.900M
YoY Change -1170.59% 0.0% -40.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.40M 6.200M 3.900M
YoY Change 24.07% 58.97% 56.0%
NET CHANGE
Cash From Operating Activities 6.300M 19.40M 19.00M
Cash From Investing Activities -36.40M -1.900M -1.900M
Cash From Financing Activities 13.40M 6.200M 3.900M
Net Change In Cash -16.70M 23.70M 21.00M
YoY Change -163.02% 12.86% 35.48%
FREE CASH FLOW
Cash From Operating Activities $6.300M $19.40M $19.00M
Capital Expenditures -$5.400M -$3.100M -$2.500M
Free Cash Flow $11.70M $22.50M $21.50M
YoY Change -18.18% 4.65% 8.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1500000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000883984
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15976438 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ICU MEDICAL INC/DE
CY2015Q3 icui Buyoutagreement
Buyoutagreement
1800000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
100000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1106000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
709000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7729000 USD
CY2015Q2 icui Debt Securities Maturity Date Range High
DebtSecuritiesMaturityDateRangeHigh
2036
CY2015Q3 icui Debt Securities Maturity Date Range Low
DebtSecuritiesMaturityDateRangeLow
2015
CY2015Q3 icui Grosslegalsettlementaward
Grosslegalsettlementaward
8800000 USD
icui Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
-3098000 USD
icui Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
-5177000 USD
icui Legal Settlement Charge For Legal Fees
LegalSettlementChargeForLegalFees
700000 USD
icui Legalsettlementcharge
Legalsettlementcharge
6500000 USD
CY2014Q3 icui Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.
Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.
0 USD
icui Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.
Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.
0 USD
CY2015Q3 icui Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.
Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.
-5261000 USD
icui Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.
Legalsettlementsincludingamountsawardedinadisputeandchargesamountspaidoutinaseparatedispute.
1798000 USD
CY2015Q3 icui Net Book Valueof Building
NetBookValueofBuilding
2500000 USD
icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
-488000 USD
icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
38000 USD
CY2014Q3 icui Restructuringandstrategictransaction
Restructuringandstrategictransaction
2840000 USD
icui Restructuringandstrategictransaction
Restructuringandstrategictransaction
2840000 USD
CY2015Q3 icui Restructuringandstrategictransaction
Restructuringandstrategictransaction
3411000 USD
icui Restructuringandstrategictransaction
Restructuringandstrategictransaction
3411000 USD
CY2015Q4 icui Saleofassetsacquiredinacquisition
Saleofassetsacquiredinacquisition
27000000 USD
CY2015Q3 icui Sellingpriceofbuilding
Sellingpriceofbuilding
3600000 USD
CY2015Q3 icui Treasury Stock Purchase Plan
TreasuryStockPurchasePlan
40000000 USD
CY2015Q3 icui Treasury Stock Purchase Plan Remaining Available
TreasuryStockPurchasePlanRemainingAvailable
22500000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11378000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
14732000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39051000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49242000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17350000 USD
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22471000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
138623000 USD
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
146314000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9554000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17273000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
107336000 USD
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
134413000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1127000 USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1123000 USD
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
211000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
235000 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44000 shares
CY2014Q4 us-gaap Assets
Assets
541102000 USD
CY2015Q3 us-gaap Assets
Assets
610228000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
437212000 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
513697000 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
70952000 USD
CY2015Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
38695000 USD
CY2015Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1100000 USD
CY2015Q4 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
59500000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
226022000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
252241000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
275812000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
355368000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
355368000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26219000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
79556000 USD
CY2014Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
346764000 USD
CY2015Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
394063000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15595000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15951000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15595000 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15951000 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1559000 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
1595000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-508000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
11224000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
16770000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
31803000 USD
CY2014Q4 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2015Q3 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
39310000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
117648000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
39751000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
118741000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4683000 USD
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6534000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
9258000 USD
CY2015Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
9920000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1376000 USD
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3069000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14642000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13266000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.25
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.50
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.41
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5465000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5848000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.31
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.31
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2734000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
6194000 USD
CY2014Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2015Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1086000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1086000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1102000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
1478000 USD
CY2015Q3 us-gaap Goodwill
Goodwill
1478000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
38147000 USD
us-gaap Gross Profit
GrossProfit
111716000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
46265000 USD
us-gaap Gross Profit
GrossProfit
132540000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8564000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27556000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
24998000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
57058000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2136000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8593000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8732000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17536000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
681000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3246000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9433000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11390000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2123000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6915000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4655000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4867000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2146000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8824000 USD
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
169000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
277000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
681000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
619000 shares
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7063000 USD
CY2015Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6365000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10381000 USD
CY2015Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11889000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
36933000 USD
CY2015Q3 us-gaap Inventory Net
InventoryNet
40681000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
23006000 USD
CY2015Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
23559000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3546000 USD
CY2015Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
5233000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1599000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1451000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
541102000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
610228000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28728000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
37203000 USD
CY2014Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
0 USD
CY2015Q3 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
1566000 USD
CY2014Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
2746000 USD
CY2015Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1222000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8488000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17807000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25151000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25161000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
48347000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42436000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
155000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
572000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
230000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
996000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
29738000 USD
us-gaap Operating Expenses
OperatingExpenses
84732000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
21497000 USD
us-gaap Operating Expenses
OperatingExpenses
76478000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8409000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
26984000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
24768000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
56062000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6936000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7739000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
504000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7719000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1833000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-2060000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
345000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1867000 USD
CY2014Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
128000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
367000 USD
CY2015Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
125000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
405000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
7500000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5836000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1523000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
778000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
78993000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
40217000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14924000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5818000 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14379000 USD
CY2014Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3963000 USD
CY2015Q3 us-gaap Prepaid Taxes
PrepaidTaxes
8798000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
69470000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
70293000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3592000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9105000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10974000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2485000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2162000 USD
CY2014Q3 us-gaap Profit Loss
ProfitLoss
6428000 USD
us-gaap Profit Loss
ProfitLoss
18963000 USD
CY2015Q3 us-gaap Profit Loss
ProfitLoss
16266000 USD
us-gaap Profit Loss
ProfitLoss
39522000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
224714000 USD
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
225082000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86091000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78768000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
53000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5055000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13252000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4227000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11657000 USD
CY2014Q3 us-gaap Restructuring Charges
RestructuringCharges
2800000 USD
CY2015Q3 us-gaap Restructuring Charges
RestructuringCharges
2300000 USD
CY2015Q3 us-gaap Restructuring Reserve
RestructuringReserve
2300000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
408911000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
448433000 USD
CY2014Q3 us-gaap Revenues
Revenues
77457000 USD
us-gaap Revenues
Revenues
229364000 USD
CY2015Q3 us-gaap Revenues
Revenues
86016000 USD
us-gaap Revenues
Revenues
251281000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
77329000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
228997000 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
85891000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
250876000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21843000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68640000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20206000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
60698000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6990000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9305000 USD
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
17299 shares
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
508252000 USD
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
567168000 USD
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15488000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15497000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16575000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16409000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15319000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15220000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15894000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15790000 shares
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In September 2015, the Financial Accounting Standards Board ("FASB") issued ASU No. 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 requires that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined, including the cumulative effect of the change in provisional amount as if the accounting had been completed at the acquisition date. The adjustments related to previous reporting periods since the acquisition date must be disclosed by income statement line item either on the face of the income statement or in the notes. The amendments are effective prospectively for the fiscal years, and interim reporting periods within those years, beginning on or after December&#160;15, 2015 (early adoption is permitted only for financial statements that have not been issued). We do not anticipate a material impact on our consolidated financial statements from adoption of this ASU.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued ASU No. 2015-11 Inventory (Topic 330): Simplifying the Measurement of Inventory. ASU 2015-11 changes the measurement of inventory from lower of cost or market to lower of cost and net realizable value. The amendments are effective prospectively for the fiscal years, and interim reporting periods within those years, beginning on or after December&#160;15, 2016. We do not anticipate a material impact on our consolidated financial statements from adoption of this ASU.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. This guidance requires that an entity depict the consideration by applying a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. On April 1, 2015, the FASB voted for a one-year deferral of the effective date of the new revenue recognition standard, ASU No. 2014-09.&#160; On July 15, 2015, the FASB affirmed these changes, which requires public entities to apply the amendments in ASU 2014-09 for annual reporting beginning after December 15, 2017. Early adoption is permitted beginning after December 31, 2016, the original effective date in ASU 2014-09. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2014, the FASB issued ASU No. 2014-12, Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide that a Performance Target Could be Achieved after the Requisite Service Period. ASU 2014-12 requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in ASU 2014-12 are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Early adoption is permitted. Entities may apply the amendments in ASU 2014-12 either: (a) prospectively to all awards granted or modified after the effective date; or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. This guidance will become effective for us at the beginning of the first quarter of 2016. We do not anticipate a material impact on our consolidated financial statements from adoption of this ASU.</font></div></div>

Files In Submission

Name View Source Status
0000883984-15-000046-index-headers.html Edgar Link pending
0000883984-15-000046-index.html Edgar Link pending
0000883984-15-000046.txt Edgar Link pending
0000883984-15-000046-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
icui-20150930.xml Edgar Link completed
icui-20150930.xsd Edgar Link pending
icui-20150930_cal.xml Edgar Link unprocessable
icui-20150930_def.xml Edgar Link unprocessable
icui-20150930_lab.xml Edgar Link unprocessable
icui-20150930_pre.xml Edgar Link unprocessable
icui-ex311_20150930x10q.htm Edgar Link pending
icui-ex312_x20150930x10q.htm Edgar Link pending
icui-ex321_x20150930x10q.htm Edgar Link pending
icui0930201510-q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending